GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » EV-to-EBIT

No.25 Central Pharmaceutical JSC (HSTC:UPH) EV-to-EBIT : (As of Jun. 26, 2025)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, No.25 Central Pharmaceutical JSC's Enterprise Value is ₫0.00 Mil. No.25 Central Pharmaceutical JSC does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate No.25 Central Pharmaceutical JSC's EV-to-EBIT at this moment.

The historical rank and industry rank for No.25 Central Pharmaceutical JSC's EV-to-EBIT or its related term are showing as below:

HSTC:UPH's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 16.915
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. No.25 Central Pharmaceutical JSC's Enterprise Value for the quarter that ended in . 20 was ₫0.00 Mil. No.25 Central Pharmaceutical JSC does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate No.25 Central Pharmaceutical JSC's Earnings Yield (Joel Greenblatt) % at this moment.

No.25 Central Pharmaceutical JSC EV-to-EBIT Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC EV-to-EBIT Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
EV-to-EBIT

No.25 Central Pharmaceutical JSC Semi-Annual Data
EV-to-EBIT

Competitive Comparison of No.25 Central Pharmaceutical JSC's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, No.25 Central Pharmaceutical JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

No.25 Central Pharmaceutical JSC's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, No.25 Central Pharmaceutical JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where No.25 Central Pharmaceutical JSC's EV-to-EBIT falls into.


;
;

No.25 Central Pharmaceutical JSC EV-to-EBIT Calculation

No.25 Central Pharmaceutical JSC's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

No.25 Central Pharmaceutical JSC  (HSTC:UPH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

No.25 Central Pharmaceutical JSC's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

No.25 Central Pharmaceutical JSC EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

No.25 Central Pharmaceutical JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » EV-to-EBIT
Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
Website
https://uphace.vn
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines